SWK Holdings Corporation Overview
Pro stress-test →SWK Holdings is a life science-focused specialty finance company that provides non-dilutive financing to small- and mid-sized commercial-stage healthcare companies to fuel development and commercialization of medical technologies and products. The company operates through two primary segments: Finance Receivables (royalty and financing solutions) and Pharmaceutical Development (through its Enteris BioPharma subsidiary).
Strategic Profile
Pro stress-test →As a venture debt firm specializing in early-stage through growth-stage capital investments, SWK focuses on healthcare sectors including biopharma, medical devices, diagnostics, and life science tools, alongside technology and green energy/sustainability. SWK specializes in tailored capital solutions that preserve partners' ownership interests.
Competitive Landscape
Pro stress-test →SWK competes in the specialized finance sector focused on global healthcare, providing capital to a broad range of life science companies, institutions, and inventors. Key competitors include other healthcare-focused specialty finance and venture debt providers such as Silicon Valley Bank's healthcare lending division (now bridging SVBB assets), Horizon Technology Finance, and Heritage Insurance Holdings (healthcare-focused lending). SWK's niche focus on royalty financing and non-dilutive solutions differentiates it from traditional venture capital.
Industry Context
SWK Holdings Corporation operates in Specialty Finance / Healthcare Capital / Venture Debt.
Key facts
Founded: 1996 · Headquarters: Dallas, Texas · Revenue: $27.55M (2024) · Market cap: $208M